These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 514940)

  • 21. [Use of intravenous disopyramide in 126 cases of cardiac rhythm disorders (author's transl)].
    Ducloux G; Faivre G; Perrin A; Raynaud R; Canicave JC; Fauchier JP; Groussin P; Loire R; Saulnier JP
    Ann Cardiol Angeiol (Paris); 1978; 27(4):297-302. PubMed ID: 80150
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical experimentation with intravenously administered disopyramide].
    Vandenbosch R; Lisin N; Andriange M; Gach J; Carlier J
    Acta Cardiol; 1975; 30(4):267-78. PubMed ID: 1084657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia.
    Vismara LA; Vera Z; Miller RR; Mason DT
    Am J Cardiol; 1977 Jun; 39(7):1027-34. PubMed ID: 326016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ventricular tachycardia-flutter associated with disopyramide therapy: a report of three cases.
    Dhurandhar RW; Nademanee K; Goldman AM
    Heart Lung; 1978; 7(5):783-7. PubMed ID: 250503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
    Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
    G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease.
    Sandler G
    J Int Med Res; 1977; 5(5):369-73. PubMed ID: 913864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Electrophysiologic study of disopyramide].
    Ponsonnaille J; Marcheix JC; Datchary J; Gras H
    Ann Cardiol Angeiol (Paris); 1979; 28(1):49-52. PubMed ID: 434759
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical studies of Norpace (Part V).
    Cook WR
    Angiology; 1975 Jan; 26(1 Pt 2):140-1. PubMed ID: 1115401
    [No Abstract]   [Full Text] [Related]  

  • 29. Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial.
    Sbarbaro JA; Rawling DA; Fozzard HA
    Am J Cardiol; 1979 Sep; 44(3):513-20. PubMed ID: 474432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of disturbances of cardiac rhythm using intravenous disopyramide].
    Lisin N; Andriange M; Vandenbosch R; Carlier J
    Rev Med Liege; 1974 May; 29(9):256-64. PubMed ID: 4134825
    [No Abstract]   [Full Text] [Related]  

  • 31. Congestive heart failure caused by oral disopyramide.
    Podrid PJ; Schoeneberger A; Lown B
    N Engl J Med; 1980 Mar; 302(11):614-7. PubMed ID: 7351909
    [No Abstract]   [Full Text] [Related]  

  • 32. [Letter: Syncopes through the inversion of points in connection with the absorption of disopyramide].
    Casedevant B; Sabaut D; Clementy J; Dallocchio M
    Nouv Presse Med; 1975 Oct; 4(32):2339. PubMed ID: 1178509
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction.
    Pouleur H; Chaudron JM; Reyns P
    Eur J Cardiol; 1977 Jul; 5(5):397-404. PubMed ID: 330168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disopyramide-induced ventricular tachycardia.
    Lo KS; Gantz KB; Stetson PL; Lucchesi BR; Pitt B
    Arch Intern Med; 1980 Mar; 140(3):413-4. PubMed ID: 6153888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Action of injectable disopyramide phosphate in the emergency treatment of ventricular tachycardia].
    Valère PE; Guerot C; Castillo Fenoy A; Branvin E; Urbanczyk A; Tricot R
    Coeur Med Interne; 1977; 16(2):285-92. PubMed ID: 891126
    [No Abstract]   [Full Text] [Related]  

  • 36. [Electrocardiographic disturbances induced by the simultaneous administration of indapamide and disopyramide].
    Cosma C; Pauly-Laubry C; Py J
    Nouv Presse Med; 1978 Nov; 7(38):3455. PubMed ID: 740527
    [No Abstract]   [Full Text] [Related]  

  • 37. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards.
    Zainal N; Carmichael DJ; Griffiths JW; Besterman EM; Kidner PH; Gillham AD; Summers GD
    Lancet; 1977 Oct; 2(8044):887-9. PubMed ID: 72237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some cardiovascular problems with disopyramide.
    Warrington SJ; Hamer J
    Postgrad Med J; 1980 Apr; 56(654):229-33. PubMed ID: 7433320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disopyramide-induced QT prolongation and ventricular tachyarrhythmias.
    Riccioni N; Castiglioni M; Bartolomei C
    Am Heart J; 1983 May; 105(5):870-1. PubMed ID: 6846134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.